questions for the investor briefing evening

Unfortunately I won't be attending because of the travel distance involved. I was wondering if any HC members on this thread would be attending, if so could we have a collection of questions/concerns on this thread in which they would be willing to take to the meeting.

I have emailed MR re the progress of the patient/s administered the CVac treatment back in march 09. He has declined to respond to this question in his replies (understandably it would be market sensitive)

http://imagesignal.comsec.com.au/asxdata/20090306/pdf/00934362.pdf

http://imagesignal.comsec.com.au/asxdata/20090316/pdf/00936835.pdf

IMO It is pointless having a investor briefing if management are only going to repeat what has already been reported to the market re ASX announcements.

Therefore my question to take to the meeting would be:
1. How are the patients who are receiving the CVac treatment via the Australian Regulatory
Control Mechanism’s Special Access Scheme under the TGA progressing?

Thanks in advance, boiler